U.S., Sept. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07167381) titled 'xDRIVE for Florida-based Cancer Patients' on Aug. 24.
Brief Summary: Through this study funded by the Florida Cancer Innovation Fund, First Ascent will demonstrate state-wide feasibility of providing xDRIVE Functional Precision Medicine + Artificial Intelligence platform by assessing patient clinical benefit and health economics impacts. As this is a feasibility study, results will be returned to the physician and the physician may use the data to inform the next line of treatment. The investigator will run a prospective single-arm feasibility study providing the xDRIVE FPM AI platform to n = 210+ cancer patients throughout the sta...